Comparison of the effect of vasopressin and tranexamic acid on gastrointestinal bleeding

Phase 3

Recruiting

• Conditions: Gastrointestinal bleeding.; Gastrointestinal hemorrhage, unspecified; K92.2

• Registration Number: IRCT20190717044255N2
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

All patients with a diagnosis of severe upper or lower gastrointestinal bleeding

Exclusion Criteria

Previous allergy to vasopressin or tranexamic acid
coagulation disorders
Suspected acute myocardial infarction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gastrointestinal bleeding volume. Timepoint: During the first 24 hours after receiving the drug. Method of measurement: Using a Calibrated container or non-sterile gas (each blood gas completely impregnate with equivalent to 20 ml blood ).

Secondary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Every 30 minutes to 24 hours after receiving the drug. Method of measurement: Automatic arm pressure gauge cuff.;Pulse rate. Timepoint: Every 30 minutes to 24 hours after receiving the drug. Method of measurement: Pulse oximeter device.;Patients venous hemoglobin concentration. Timepoint: When patients are admitted to the emergency room and then every 6 hours, up to 24 hours after receiving the drug. Method of measurement: Based on laboratory results by Cell counter device model H1.